nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RXRB—breast cancer	0.352	0.591	CbGaD
Isotretinoin—RARB—breast cancer	0.244	0.409	CbGaD
Isotretinoin—RARA—mammary gland—breast cancer	0.00243	0.0609	CbGeAlD
Isotretinoin—RARG—nipple—breast cancer	0.00214	0.0536	CbGeAlD
Isotretinoin—RXRA—female reproductive system—breast cancer	0.00146	0.0366	CbGeAlD
Isotretinoin—RXRG—pituitary gland—breast cancer	0.0014	0.0351	CbGeAlD
Isotretinoin—RXRG—adipose tissue—breast cancer	0.00139	0.0349	CbGeAlD
Isotretinoin—RARG—skin of body—breast cancer	0.00137	0.0343	CbGeAlD
Isotretinoin—RXRA—female gonad—breast cancer	0.00133	0.0333	CbGeAlD
Isotretinoin—RARB—female reproductive system—breast cancer	0.00131	0.0328	CbGeAlD
Isotretinoin—RARB—adrenal gland—breast cancer	0.00128	0.0321	CbGeAlD
Isotretinoin—RXRG—adrenal gland—breast cancer	0.00125	0.0313	CbGeAlD
Isotretinoin—RXRA—endocrine gland—breast cancer	0.00123	0.0309	CbGeAlD
Isotretinoin—RARA—endometrium—breast cancer	0.00121	0.0304	CbGeAlD
Isotretinoin—RARB—female gonad—breast cancer	0.00119	0.0299	CbGeAlD
Isotretinoin—RARG—uterus—breast cancer	0.00119	0.0298	CbGeAlD
Isotretinoin—RXRB—adrenal gland—breast cancer	0.00117	0.0295	CbGeAlD
Isotretinoin—RARG—adipose tissue—breast cancer	0.00116	0.0291	CbGeAlD
Isotretinoin—RARA—uterus—breast cancer	0.00112	0.028	CbGeAlD
Isotretinoin—RARB—endocrine gland—breast cancer	0.00111	0.0278	CbGeAlD
Isotretinoin—RARA—pituitary gland—breast cancer	0.0011	0.0275	CbGeAlD
Isotretinoin—RXRB—female gonad—breast cancer	0.0011	0.0275	CbGeAlD
Isotretinoin—RARA—adipose tissue—breast cancer	0.00109	0.0274	CbGeAlD
Isotretinoin—RXRG—endocrine gland—breast cancer	0.00108	0.0272	CbGeAlD
Isotretinoin—RARG—female reproductive system—breast cancer	0.00107	0.0268	CbGeAlD
Isotretinoin—RARG—adrenal gland—breast cancer	0.00104	0.0261	CbGeAlD
Isotretinoin—RXRB—endocrine gland—breast cancer	0.00102	0.0255	CbGeAlD
Isotretinoin—RARA—female reproductive system—breast cancer	0.001	0.0252	CbGeAlD
Isotretinoin—RARA—adrenal gland—breast cancer	0.00098	0.0246	CbGeAlD
Isotretinoin—RARG—female gonad—breast cancer	0.000972	0.0244	CbGeAlD
Isotretinoin—RARA—bone marrow—breast cancer	0.000948	0.0238	CbGeAlD
Isotretinoin—Vitamin A—ALDH1A1—breast cancer	0.000934	0.158	CrCbGaD
Isotretinoin—RARA—female gonad—breast cancer	0.000914	0.0229	CbGeAlD
Isotretinoin—Tretinoin—ALDH1A1—breast cancer	0.000902	0.153	CrCbGaD
Isotretinoin—RARA—endocrine gland—breast cancer	0.00085	0.0213	CbGeAlD
Isotretinoin—Acitretin—RXRB—breast cancer	0.000809	0.137	CrCbGaD
Isotretinoin—Alitretinoin—RXRB—breast cancer	0.000776	0.132	CrCbGaD
Isotretinoin—RARB—lymph node—breast cancer	0.000766	0.0192	CbGeAlD
Isotretinoin—RARG—lymph node—breast cancer	0.000625	0.0157	CbGeAlD
Isotretinoin—RARA—lymph node—breast cancer	0.000588	0.0147	CbGeAlD
Isotretinoin—Acitretin—RARB—breast cancer	0.000561	0.0951	CrCbGaD
Isotretinoin—Tretinoin—RXRB—breast cancer	0.000546	0.0927	CrCbGaD
Isotretinoin—Alitretinoin—RARB—breast cancer	0.000538	0.0912	CrCbGaD
Isotretinoin—Tretinoin—RARB—breast cancer	0.000379	0.0643	CrCbGaD
Isotretinoin—Vitamin A—CYP1A1—breast cancer	0.00011	0.0187	CrCbGaD
Isotretinoin—Tretinoin—CYP1A1—breast cancer	0.000106	0.018	CrCbGaD
Isotretinoin—Acitretin—ALB—breast cancer	8.76e-05	0.0149	CrCbGaD
Isotretinoin—Alitretinoin—ABCB1—breast cancer	8.01e-05	0.0136	CrCbGaD
Isotretinoin—Tretinoin—CYP3A4—breast cancer	6.78e-05	0.0115	CrCbGaD
Isotretinoin—Insomnia—Capecitabine—breast cancer	1.79e-05	8.84e-05	CcSEcCtD
Isotretinoin—Hypoaesthesia—Doxorubicin—breast cancer	1.79e-05	8.83e-05	CcSEcCtD
Isotretinoin—Rash—Fluorouracil—breast cancer	1.79e-05	8.82e-05	CcSEcCtD
Isotretinoin—Dermatitis—Fluorouracil—breast cancer	1.79e-05	8.81e-05	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—breast cancer	1.79e-05	8.8e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Capecitabine—breast cancer	1.78e-05	8.78e-05	CcSEcCtD
Isotretinoin—Decreased appetite—Docetaxel—breast cancer	1.78e-05	8.78e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Paclitaxel—breast cancer	1.78e-05	8.78e-05	CcSEcCtD
Isotretinoin—Headache—Fluorouracil—breast cancer	1.78e-05	8.77e-05	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—breast cancer	1.78e-05	8.76e-05	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—breast cancer	1.77e-05	8.74e-05	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Docetaxel—breast cancer	1.77e-05	8.72e-05	CcSEcCtD
Isotretinoin—Dyspnoea—Capecitabine—breast cancer	1.77e-05	8.72e-05	CcSEcCtD
Isotretinoin—Fatigue—Docetaxel—breast cancer	1.77e-05	8.71e-05	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—breast cancer	1.76e-05	8.7e-05	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—breast cancer	1.76e-05	8.7e-05	CcSEcCtD
Isotretinoin—Nausea—Irinotecan—breast cancer	1.76e-05	8.68e-05	CcSEcCtD
Isotretinoin—Nausea—Mitoxantrone—breast cancer	1.76e-05	8.68e-05	CcSEcCtD
Isotretinoin—Pain—Docetaxel—breast cancer	1.75e-05	8.64e-05	CcSEcCtD
Isotretinoin—Constipation—Docetaxel—breast cancer	1.75e-05	8.64e-05	CcSEcCtD
Isotretinoin—Back pain—Methotrexate—breast cancer	1.75e-05	8.63e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Capecitabine—breast cancer	1.75e-05	8.61e-05	CcSEcCtD
Isotretinoin—Chills—Epirubicin—breast cancer	1.74e-05	8.6e-05	CcSEcCtD
Isotretinoin—Arrhythmia—Epirubicin—breast cancer	1.74e-05	8.57e-05	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—breast cancer	1.73e-05	8.55e-05	CcSEcCtD
Isotretinoin—Asthenia—Paclitaxel—breast cancer	1.73e-05	8.55e-05	CcSEcCtD
Isotretinoin—Decreased appetite—Capecitabine—breast cancer	1.72e-05	8.5e-05	CcSEcCtD
Isotretinoin—Alopecia—Epirubicin—breast cancer	1.72e-05	8.47e-05	CcSEcCtD
Isotretinoin—Nausea—Gemcitabine—breast cancer	1.71e-05	8.45e-05	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Capecitabine—breast cancer	1.71e-05	8.44e-05	CcSEcCtD
Isotretinoin—Fatigue—Capecitabine—breast cancer	1.71e-05	8.43e-05	CcSEcCtD
Isotretinoin—Pruritus—Paclitaxel—breast cancer	1.71e-05	8.43e-05	CcSEcCtD
Isotretinoin—Vision blurred—Methotrexate—breast cancer	1.7e-05	8.41e-05	CcSEcCtD
Isotretinoin—Mental disorder—Epirubicin—breast cancer	1.7e-05	8.4e-05	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—breast cancer	1.7e-05	8.39e-05	CcSEcCtD
Isotretinoin—Constipation—Capecitabine—breast cancer	1.7e-05	8.36e-05	CcSEcCtD
Isotretinoin—Pain—Capecitabine—breast cancer	1.7e-05	8.36e-05	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—breast cancer	1.69e-05	8.35e-05	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—breast cancer	1.69e-05	8.35e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Docetaxel—breast cancer	1.69e-05	8.32e-05	CcSEcCtD
Isotretinoin—Nausea—Fluorouracil—breast cancer	1.69e-05	8.31e-05	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—breast cancer	1.68e-05	8.29e-05	CcSEcCtD
Isotretinoin—Ill-defined disorder—Methotrexate—breast cancer	1.68e-05	8.28e-05	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—breast cancer	1.68e-05	8.27e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Docetaxel—breast cancer	1.67e-05	8.26e-05	CcSEcCtD
Isotretinoin—Anaemia—Methotrexate—breast cancer	1.67e-05	8.24e-05	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—breast cancer	1.67e-05	8.23e-05	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—breast cancer	1.67e-05	8.22e-05	CcSEcCtD
Isotretinoin—Tension—Epirubicin—breast cancer	1.66e-05	8.19e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Paclitaxel—breast cancer	1.65e-05	8.15e-05	CcSEcCtD
Isotretinoin—Nervousness—Epirubicin—breast cancer	1.64e-05	8.11e-05	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—breast cancer	1.64e-05	8.07e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Capecitabine—breast cancer	1.63e-05	8.06e-05	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—breast cancer	1.63e-05	8.05e-05	CcSEcCtD
Isotretinoin—Malaise—Methotrexate—breast cancer	1.63e-05	8.04e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Capecitabine—breast cancer	1.62e-05	8e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Docetaxel—breast cancer	1.62e-05	7.98e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Docetaxel—breast cancer	1.62e-05	7.98e-05	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—breast cancer	1.61e-05	7.96e-05	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—breast cancer	1.61e-05	7.93e-05	CcSEcCtD
Isotretinoin—Dizziness—Paclitaxel—breast cancer	1.6e-05	7.88e-05	CcSEcCtD
Isotretinoin—Vision blurred—Epirubicin—breast cancer	1.6e-05	7.87e-05	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—breast cancer	1.59e-05	7.84e-05	CcSEcCtD
Isotretinoin—Cough—Methotrexate—breast cancer	1.58e-05	7.78e-05	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—breast cancer	1.58e-05	7.77e-05	CcSEcCtD
Isotretinoin—Urticaria—Capecitabine—breast cancer	1.58e-05	7.77e-05	CcSEcCtD
Isotretinoin—Ill-defined disorder—Epirubicin—breast cancer	1.57e-05	7.74e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Capecitabine—breast cancer	1.57e-05	7.73e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Capecitabine—breast cancer	1.57e-05	7.73e-05	CcSEcCtD
Isotretinoin—Convulsion—Methotrexate—breast cancer	1.57e-05	7.73e-05	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—breast cancer	1.57e-05	7.72e-05	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—breast cancer	1.57e-05	7.72e-05	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—breast cancer	1.56e-05	7.71e-05	CcSEcCtD
Isotretinoin—Agitation—Epirubicin—breast cancer	1.56e-05	7.67e-05	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—breast cancer	1.54e-05	7.61e-05	CcSEcCtD
Isotretinoin—Arthralgia—Methotrexate—breast cancer	1.54e-05	7.59e-05	CcSEcCtD
Isotretinoin—Chest pain—Methotrexate—breast cancer	1.54e-05	7.59e-05	CcSEcCtD
Isotretinoin—Myalgia—Methotrexate—breast cancer	1.54e-05	7.59e-05	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—breast cancer	1.54e-05	7.58e-05	CcSEcCtD
Isotretinoin—Vomiting—Paclitaxel—breast cancer	1.54e-05	7.58e-05	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.53e-05	7.54e-05	CcSEcCtD
Isotretinoin—Malaise—Epirubicin—breast cancer	1.53e-05	7.53e-05	CcSEcCtD
Isotretinoin—Rash—Paclitaxel—breast cancer	1.52e-05	7.51e-05	CcSEcCtD
Isotretinoin—Dermatitis—Paclitaxel—breast cancer	1.52e-05	7.51e-05	CcSEcCtD
Isotretinoin—Discomfort—Methotrexate—breast cancer	1.52e-05	7.5e-05	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—breast cancer	1.52e-05	7.5e-05	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—breast cancer	1.52e-05	7.48e-05	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—breast cancer	1.52e-05	7.47e-05	CcSEcCtD
Isotretinoin—Headache—Paclitaxel—breast cancer	1.51e-05	7.46e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Docetaxel—breast cancer	1.51e-05	7.44e-05	CcSEcCtD
Isotretinoin—Palpitations—Epirubicin—breast cancer	1.5e-05	7.38e-05	CcSEcCtD
Isotretinoin—Confusional state—Methotrexate—breast cancer	1.49e-05	7.34e-05	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—breast cancer	1.49e-05	7.34e-05	CcSEcCtD
Isotretinoin—Cough—Epirubicin—breast cancer	1.48e-05	7.28e-05	CcSEcCtD
Isotretinoin—Anaphylactic shock—Methotrexate—breast cancer	1.48e-05	7.28e-05	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—breast cancer	1.48e-05	7.28e-05	CcSEcCtD
Isotretinoin—Asthenia—Docetaxel—breast cancer	1.47e-05	7.25e-05	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—breast cancer	1.47e-05	7.23e-05	CcSEcCtD
Isotretinoin—Infection—Methotrexate—breast cancer	1.47e-05	7.23e-05	CcSEcCtD
Isotretinoin—Hypertension—Epirubicin—breast cancer	1.46e-05	7.21e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Capecitabine—breast cancer	1.46e-05	7.2e-05	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—breast cancer	1.45e-05	7.17e-05	CcSEcCtD
Isotretinoin—Pruritus—Docetaxel—breast cancer	1.45e-05	7.15e-05	CcSEcCtD
Isotretinoin—Nervous system disorder—Methotrexate—breast cancer	1.45e-05	7.14e-05	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—breast cancer	1.45e-05	7.14e-05	CcSEcCtD
Isotretinoin—Thrombocytopenia—Methotrexate—breast cancer	1.45e-05	7.13e-05	CcSEcCtD
Isotretinoin—Myalgia—Epirubicin—breast cancer	1.44e-05	7.11e-05	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—breast cancer	1.44e-05	7.11e-05	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—breast cancer	1.44e-05	7.11e-05	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—breast cancer	1.44e-05	7.1e-05	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—breast cancer	1.44e-05	7.08e-05	CcSEcCtD
Isotretinoin—Nausea—Paclitaxel—breast cancer	1.44e-05	7.08e-05	CcSEcCtD
Isotretinoin—Skin disorder—Methotrexate—breast cancer	1.43e-05	7.07e-05	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.43e-05	7.06e-05	CcSEcCtD
Isotretinoin—Hyperhidrosis—Methotrexate—breast cancer	1.43e-05	7.04e-05	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—breast cancer	1.42e-05	7.02e-05	CcSEcCtD
Isotretinoin—Asthenia—Capecitabine—breast cancer	1.42e-05	7.02e-05	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—breast cancer	1.41e-05	6.96e-05	CcSEcCtD
Isotretinoin—Dry mouth—Epirubicin—breast cancer	1.41e-05	6.95e-05	CcSEcCtD
Isotretinoin—Anorexia—Methotrexate—breast cancer	1.41e-05	6.94e-05	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—breast cancer	1.4e-05	6.93e-05	CcSEcCtD
Isotretinoin—Pruritus—Capecitabine—breast cancer	1.4e-05	6.92e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Docetaxel—breast cancer	1.4e-05	6.91e-05	CcSEcCtD
Isotretinoin—Confusional state—Epirubicin—breast cancer	1.39e-05	6.87e-05	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—breast cancer	1.38e-05	6.82e-05	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—breast cancer	1.38e-05	6.81e-05	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—breast cancer	1.38e-05	6.81e-05	CcSEcCtD
Isotretinoin—Hypotension—Methotrexate—breast cancer	1.38e-05	6.8e-05	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—breast cancer	1.38e-05	6.79e-05	CcSEcCtD
Isotretinoin—Infection—Epirubicin—breast cancer	1.37e-05	6.77e-05	CcSEcCtD
Isotretinoin—Cough—Doxorubicin—breast cancer	1.37e-05	6.74e-05	CcSEcCtD
Isotretinoin—Shock—Epirubicin—breast cancer	1.36e-05	6.7e-05	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—breast cancer	1.36e-05	6.69e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Capecitabine—breast cancer	1.36e-05	6.69e-05	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—breast cancer	1.35e-05	6.68e-05	CcSEcCtD
Isotretinoin—Dizziness—Docetaxel—breast cancer	1.35e-05	6.68e-05	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—breast cancer	1.35e-05	6.67e-05	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—breast cancer	1.35e-05	6.67e-05	CcSEcCtD
Isotretinoin—Tachycardia—Epirubicin—breast cancer	1.35e-05	6.65e-05	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Methotrexate—breast cancer	1.34e-05	6.63e-05	CcSEcCtD
Isotretinoin—Skin disorder—Epirubicin—breast cancer	1.34e-05	6.62e-05	CcSEcCtD
Isotretinoin—Hyperhidrosis—Epirubicin—breast cancer	1.34e-05	6.59e-05	CcSEcCtD
Isotretinoin—Insomnia—Methotrexate—breast cancer	1.34e-05	6.58e-05	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—breast cancer	1.33e-05	6.57e-05	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—breast cancer	1.33e-05	6.57e-05	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—breast cancer	1.33e-05	6.57e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—AR—breast cancer	1.33e-05	8.6e-05	CbGpPWpGaD
Isotretinoin—Anxiety—Doxorubicin—breast cancer	1.33e-05	6.55e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Methotrexate—breast cancer	1.33e-05	6.54e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.32e-05	8.57e-05	CbGpPWpGaD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.32e-05	6.53e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.32e-05	8.55e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GPI—breast cancer	1.32e-05	8.53e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HADHB—breast cancer	1.32e-05	8.53e-05	CbGpPWpGaD
Isotretinoin—Discomfort—Doxorubicin—breast cancer	1.32e-05	6.5e-05	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—breast cancer	1.32e-05	6.49e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—H2AFX—breast cancer	1.32e-05	8.51e-05	CbGpPWpGaD
Isotretinoin—Dyspnoea—Methotrexate—breast cancer	1.32e-05	6.49e-05	CcSEcCtD
Isotretinoin—Somnolence—Methotrexate—breast cancer	1.31e-05	6.47e-05	CcSEcCtD
Isotretinoin—Dizziness—Capecitabine—breast cancer	1.31e-05	6.47e-05	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.31e-05	8.48e-05	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—TNF—breast cancer	1.31e-05	8.48e-05	CbGpPWpGaD
Isotretinoin—Dry mouth—Doxorubicin—breast cancer	1.3e-05	6.43e-05	CcSEcCtD
Isotretinoin—Vomiting—Docetaxel—breast cancer	1.3e-05	6.42e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Methotrexate—breast cancer	1.3e-05	6.41e-05	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—SMAD4—breast cancer	1.3e-05	8.38e-05	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—VDR—breast cancer	1.29e-05	8.36e-05	CbGpPWpGaD
Isotretinoin—Rash—Docetaxel—breast cancer	1.29e-05	6.37e-05	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—breast cancer	1.29e-05	6.37e-05	CcSEcCtD
Isotretinoin—Dermatitis—Docetaxel—breast cancer	1.29e-05	6.36e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.29e-05	8.34e-05	CbGpPWpGaD
Isotretinoin—Confusional state—Doxorubicin—breast cancer	1.29e-05	6.36e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—SIRT1—breast cancer	1.29e-05	8.33e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.29e-05	8.32e-05	CbGpPWpGaD
Isotretinoin—Decreased appetite—Methotrexate—breast cancer	1.28e-05	6.33e-05	CcSEcCtD
Isotretinoin—Headache—Docetaxel—breast cancer	1.28e-05	6.33e-05	CcSEcCtD
Isotretinoin—RXRA—NRF2 pathway—TGFB1—breast cancer	1.28e-05	8.27e-05	CbGpPWpGaD
Isotretinoin—Oedema—Doxorubicin—breast cancer	1.28e-05	6.3e-05	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—breast cancer	1.28e-05	6.3e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.28e-05	8.26e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Methotrexate—breast cancer	1.27e-05	6.28e-05	CcSEcCtD
Isotretinoin—Fatigue—Methotrexate—breast cancer	1.27e-05	6.28e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—SMAD4—breast cancer	1.27e-05	8.23e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—VDR—breast cancer	1.27e-05	8.21e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ERCC2—breast cancer	1.27e-05	8.21e-05	CbGpPWpGaD
Isotretinoin—Infection—Doxorubicin—breast cancer	1.27e-05	6.26e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—SIRT1—breast cancer	1.26e-05	8.17e-05	CbGpPWpGaD
Isotretinoin—Pain—Methotrexate—breast cancer	1.26e-05	6.22e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.26e-05	8.16e-05	CbGpPWpGaD
Isotretinoin—Vomiting—Capecitabine—breast cancer	1.26e-05	6.22e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—ABL1—breast cancer	1.26e-05	8.14e-05	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—breast cancer	1.26e-05	6.21e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ALDH1A1—breast cancer	1.26e-05	8.13e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALDH7A1—breast cancer	1.26e-05	8.13e-05	CbGpPWpGaD
Isotretinoin—Shock—Doxorubicin—breast cancer	1.26e-05	6.2e-05	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NCOR1—breast cancer	1.26e-05	8.13e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PABPC1—breast cancer	1.25e-05	8.11e-05	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Doxorubicin—breast cancer	1.25e-05	6.18e-05	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—breast cancer	1.25e-05	6.17e-05	CcSEcCtD
Isotretinoin—Rash—Capecitabine—breast cancer	1.25e-05	6.17e-05	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—breast cancer	1.25e-05	6.16e-05	CcSEcCtD
Isotretinoin—Dermatitis—Capecitabine—breast cancer	1.25e-05	6.16e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—SMAD4—breast cancer	1.25e-05	8.07e-05	CbGpPWpGaD
Isotretinoin—Tachycardia—Doxorubicin—breast cancer	1.25e-05	6.15e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.25e-05	8.07e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—VDR—breast cancer	1.25e-05	8.06e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.24e-05	8.05e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.24e-05	8.04e-05	CbGpPWpGaD
Isotretinoin—Headache—Capecitabine—breast cancer	1.24e-05	6.13e-05	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—breast cancer	1.24e-05	6.12e-05	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—breast cancer	1.24e-05	6.12e-05	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—breast cancer	1.24e-05	6.09e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—NCOR1—breast cancer	1.24e-05	7.99e-05	CbGpPWpGaD
Isotretinoin—Dyspnoea—Epirubicin—breast cancer	1.23e-05	6.07e-05	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—breast cancer	1.23e-05	6.06e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—SMAD4—breast cancer	1.22e-05	7.88e-05	CbGpPWpGaD
Isotretinoin—Anorexia—Doxorubicin—breast cancer	1.22e-05	6.01e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.22e-05	7.87e-05	CbGpPWpGaD
Isotretinoin—Nausea—Docetaxel—breast cancer	1.22e-05	6e-05	CcSEcCtD
Isotretinoin—Feeling abnormal—Methotrexate—breast cancer	1.22e-05	6e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—breast cancer	1.22e-05	6e-05	CcSEcCtD
Isotretinoin—RARA—Gene Expression—SIRT1—breast cancer	1.21e-05	7.84e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NCOR1—breast cancer	1.21e-05	7.84e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SIRT1—breast cancer	1.21e-05	7.84e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Methotrexate—breast cancer	1.21e-05	5.95e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ADSL—breast cancer	1.21e-05	7.8e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—FHL2—breast cancer	1.21e-05	7.8e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NME1—breast cancer	1.21e-05	7.8e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—UMPS—breast cancer	1.21e-05	7.8e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PHGDH—breast cancer	1.21e-05	7.8e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—H2AFX—breast cancer	1.2e-05	7.79e-05	CbGpPWpGaD
Isotretinoin—Decreased appetite—Epirubicin—breast cancer	1.2e-05	5.92e-05	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—NCOA1—breast cancer	1.2e-05	7.76e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SMAD4—breast cancer	1.2e-05	7.74e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SMAD4—breast cancer	1.2e-05	7.74e-05	CbGpPWpGaD
Isotretinoin—Hypotension—Doxorubicin—breast cancer	1.19e-05	5.89e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—VDR—breast cancer	1.19e-05	7.72e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—VDR—breast cancer	1.19e-05	7.72e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Epirubicin—breast cancer	1.19e-05	5.88e-05	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—breast cancer	1.19e-05	5.87e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—HES1—breast cancer	1.19e-05	7.7e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NCOR1—breast cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—BRIP1—breast cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—LDHB—breast cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HPSE—breast cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Isotretinoin—Constipation—Epirubicin—breast cancer	1.18e-05	5.83e-05	CcSEcCtD
Isotretinoin—Pain—Epirubicin—breast cancer	1.18e-05	5.83e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—H2AFX—breast cancer	1.18e-05	7.64e-05	CbGpPWpGaD
Isotretinoin—Nausea—Capecitabine—breast cancer	1.18e-05	5.81e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—DNMT3B—breast cancer	1.18e-05	7.6e-05	CbGpPWpGaD
Isotretinoin—Urticaria—Methotrexate—breast cancer	1.17e-05	5.78e-05	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—PLG—breast cancer	1.17e-05	7.56e-05	CbGpPWpGaD
Isotretinoin—Abdominal pain—Methotrexate—breast cancer	1.17e-05	5.75e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Methotrexate—breast cancer	1.17e-05	5.75e-05	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.16e-05	5.74e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—NCOR1—breast cancer	1.16e-05	7.51e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NCOR1—breast cancer	1.16e-05	7.51e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ERCC2—breast cancer	1.16e-05	7.51e-05	CbGpPWpGaD
Isotretinoin—Insomnia—Doxorubicin—breast cancer	1.16e-05	5.7e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.15e-05	7.46e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPL23A—breast cancer	1.15e-05	7.45e-05	CbGpPWpGaD
Isotretinoin—Paraesthesia—Doxorubicin—breast cancer	1.15e-05	5.66e-05	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—breast cancer	1.15e-05	7.41e-05	CbGpPWpGaD
Isotretinoin—Dyspnoea—Doxorubicin—breast cancer	1.14e-05	5.62e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—ERCC2—breast cancer	1.14e-05	7.37e-05	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Epirubicin—breast cancer	1.14e-05	5.61e-05	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—breast cancer	1.14e-05	5.6e-05	CcSEcCtD
Isotretinoin—RARA—Gene Expression—H2AFX—breast cancer	1.13e-05	7.32e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—H2AFX—breast cancer	1.13e-05	7.32e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HIST1H2BC—breast cancer	1.13e-05	7.32e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HIST1H2BK—breast cancer	1.13e-05	7.32e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Epirubicin—breast cancer	1.13e-05	5.57e-05	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—breast cancer	1.13e-05	5.55e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.12e-05	7.27e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RARB—breast cancer	1.12e-05	7.25e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCC1—breast cancer	1.12e-05	7.25e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HMMR—breast cancer	1.12e-05	7.25e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA3—breast cancer	1.12e-05	7.25e-05	CbGpPWpGaD
Isotretinoin—Decreased appetite—Doxorubicin—breast cancer	1.11e-05	5.48e-05	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—breast cancer	1.1e-05	5.44e-05	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—breast cancer	1.1e-05	5.43e-05	CcSEcCtD
Isotretinoin—Urticaria—Epirubicin—breast cancer	1.1e-05	5.41e-05	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—breast cancer	1.09e-05	5.39e-05	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—breast cancer	1.09e-05	5.39e-05	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—ERCC2—breast cancer	1.09e-05	7.06e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ERCC2—breast cancer	1.09e-05	7.06e-05	CbGpPWpGaD
Isotretinoin—Body temperature increased—Epirubicin—breast cancer	1.09e-05	5.38e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—breast cancer	1.09e-05	5.38e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Methotrexate—breast cancer	1.09e-05	5.36e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PPARGC1B—breast cancer	1.09e-05	7.02e-05	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—HMOX1—breast cancer	1.08e-05	6.98e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MED12—breast cancer	1.07e-05	6.95e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPS7—breast cancer	1.07e-05	6.95e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPS8—breast cancer	1.07e-05	6.95e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.06e-05	6.88e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ESR1—breast cancer	1.06e-05	6.86e-05	CbGpPWpGaD
Isotretinoin—Asthenia—Methotrexate—breast cancer	1.06e-05	5.22e-05	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—IL6—breast cancer	1.06e-05	6.84e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.06e-05	6.84e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.06e-05	6.84e-05	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Doxorubicin—breast cancer	1.05e-05	5.19e-05	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—breast cancer	1.05e-05	6.78e-05	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Doxorubicin—breast cancer	1.05e-05	5.15e-05	CcSEcCtD
Isotretinoin—Pruritus—Methotrexate—breast cancer	1.04e-05	5.15e-05	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—breast cancer	1.04e-05	6.7e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.03e-05	6.69e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.03e-05	6.67e-05	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—breast cancer	1.03e-05	6.65e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH1—breast cancer	1.03e-05	6.63e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA4—breast cancer	1.03e-05	6.63e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CA9—breast cancer	1.03e-05	6.63e-05	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Epirubicin—breast cancer	1.02e-05	5.02e-05	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—breast cancer	1.02e-05	5.01e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—FGFR1—breast cancer	1.01e-05	6.55e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.01e-05	6.55e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.01e-05	6.54e-05	CbGpPWpGaD
Isotretinoin—Abdominal pain—Doxorubicin—breast cancer	1.01e-05	4.98e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—breast cancer	1.01e-05	4.98e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Methotrexate—breast cancer	1.01e-05	4.98e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1e-05	6.48e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA2—breast cancer	9.99e-06	6.46e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GPX2—breast cancer	9.99e-06	6.46e-05	CbGpPWpGaD
Isotretinoin—Asthenia—Epirubicin—breast cancer	9.91e-06	4.89e-05	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR1—breast cancer	9.88e-06	6.39e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GPX4—breast cancer	9.87e-06	6.38e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SULT1A1—breast cancer	9.87e-06	6.38e-05	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—breast cancer	9.86e-06	6.38e-05	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—breast cancer	9.86e-06	6.38e-05	CbGpPWpGaD
Isotretinoin—Pruritus—Epirubicin—breast cancer	9.77e-06	4.82e-05	CcSEcCtD
Isotretinoin—Dizziness—Methotrexate—breast cancer	9.76e-06	4.81e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—LEP—breast cancer	9.74e-06	6.3e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH4—breast cancer	9.74e-06	6.3e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ESR1—breast cancer	9.71e-06	6.28e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—IDH1—breast cancer	9.64e-06	6.23e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA1—breast cancer	9.64e-06	6.23e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	9.63e-06	6.23e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	9.56e-06	6.18e-05	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH1—breast cancer	9.55e-06	6.17e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KDR—breast cancer	9.54e-06	6.17e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NAT2—breast cancer	9.53e-06	6.16e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ESR1—breast cancer	9.52e-06	6.16e-05	CbGpPWpGaD
Isotretinoin—Diarrhoea—Epirubicin—breast cancer	9.45e-06	4.66e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—breast cancer	9.42e-06	4.64e-05	CcSEcCtD
Isotretinoin—Vomiting—Methotrexate—breast cancer	9.39e-06	4.63e-05	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—NOTCH1—breast cancer	9.38e-06	6.07e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MET—breast cancer	9.34e-06	6.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CDK4—breast cancer	9.34e-06	6.04e-05	CbGpPWpGaD
Isotretinoin—Rash—Methotrexate—breast cancer	9.31e-06	4.59e-05	CcSEcCtD
Isotretinoin—Dermatitis—Methotrexate—breast cancer	9.3e-06	4.59e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—HSPA1B—breast cancer	9.29e-06	6.01e-05	CbGpPWpGaD
Isotretinoin—Headache—Methotrexate—breast cancer	9.25e-06	4.56e-05	CcSEcCtD
Isotretinoin—RARB—Gene Expression—NOTCH1—breast cancer	9.2e-06	5.95e-05	CbGpPWpGaD
Isotretinoin—Asthenia—Doxorubicin—breast cancer	9.17e-06	4.52e-05	CcSEcCtD
Isotretinoin—Dizziness—Epirubicin—breast cancer	9.14e-06	4.5e-05	CcSEcCtD
Isotretinoin—RARA—Gene Expression—ESR1—breast cancer	9.12e-06	5.9e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ESR1—breast cancer	9.12e-06	5.9e-05	CbGpPWpGaD
Isotretinoin—Pruritus—Doxorubicin—breast cancer	9.04e-06	4.46e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—NOTCH1—breast cancer	8.99e-06	5.81e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PGR—breast cancer	8.91e-06	5.76e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NOTCH1—breast cancer	8.82e-06	5.7e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NOTCH1—breast cancer	8.82e-06	5.7e-05	CbGpPWpGaD
Isotretinoin—Vomiting—Epirubicin—breast cancer	8.78e-06	4.33e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	8.78e-06	5.68e-05	CbGpPWpGaD
Isotretinoin—Nausea—Methotrexate—breast cancer	8.77e-06	4.32e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—breast cancer	8.75e-06	4.31e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—DNMT1—breast cancer	8.73e-06	5.65e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—SERPINE1—breast cancer	8.72e-06	5.64e-05	CbGpPWpGaD
Isotretinoin—Rash—Epirubicin—breast cancer	8.71e-06	4.29e-05	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—breast cancer	8.7e-06	4.29e-05	CcSEcCtD
Isotretinoin—Headache—Epirubicin—breast cancer	8.65e-06	4.27e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.62e-06	5.57e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NCOA2—breast cancer	8.57e-06	5.54e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	8.49e-06	5.49e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EZH2—breast cancer	8.46e-06	5.47e-05	CbGpPWpGaD
Isotretinoin—Dizziness—Doxorubicin—breast cancer	8.45e-06	4.17e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—DPYD—breast cancer	8.36e-06	5.41e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MED12—breast cancer	8.36e-06	5.41e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH3—breast cancer	8.28e-06	5.35e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PARP1—breast cancer	8.28e-06	5.35e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALDOA—breast cancer	8.23e-06	5.32e-05	CbGpPWpGaD
Isotretinoin—Nausea—Epirubicin—breast cancer	8.21e-06	4.05e-05	CcSEcCtD
Isotretinoin—Vomiting—Doxorubicin—breast cancer	8.13e-06	4.01e-05	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—SERPINE1—breast cancer	8.12e-06	5.25e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPS6—breast cancer	8.08e-06	5.23e-05	CbGpPWpGaD
Isotretinoin—Rash—Doxorubicin—breast cancer	8.06e-06	3.97e-05	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—breast cancer	8.05e-06	3.97e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—AKT2—breast cancer	8.04e-06	5.2e-05	CbGpPWpGaD
Isotretinoin—Headache—Doxorubicin—breast cancer	8.01e-06	3.95e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—NCOA3—breast cancer	7.99e-06	5.17e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SERPINE1—breast cancer	7.98e-06	5.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC2A2—breast cancer	7.93e-06	5.13e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.85e-06	5.08e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR2—breast cancer	7.84e-06	5.07e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SERPINE1—breast cancer	7.82e-06	5.06e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP2—breast cancer	7.79e-06	5.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CPT1A—breast cancer	7.77e-06	5.03e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTR—breast cancer	7.77e-06	5.03e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCG2—breast cancer	7.77e-06	5.03e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HPGDS—breast cancer	7.62e-06	4.93e-05	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—breast cancer	7.59e-06	3.74e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—HBA1—breast cancer	7.57e-06	4.9e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SERPINE1—breast cancer	7.5e-06	4.85e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SERPINE1—breast cancer	7.5e-06	4.85e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH2—breast cancer	7.43e-06	4.8e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ACHE—breast cancer	7.39e-06	4.78e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTT1—breast cancer	7.39e-06	4.78e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NCOA1—breast cancer	7.22e-06	4.67e-05	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.17e-06	4.64e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP17A1—breast cancer	7e-06	4.52e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AR—breast cancer	6.93e-06	4.48e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS1—breast cancer	6.93e-06	4.48e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ENO1—breast cancer	6.93e-06	4.48e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.9e-06	4.46e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—RAF1—breast cancer	6.9e-06	4.46e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—RELA—breast cancer	6.87e-06	4.44e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ERBB2—breast cancer	6.82e-06	4.41e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.81e-06	4.41e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP2D6—breast cancer	6.79e-06	4.39e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOA2—breast cancer	6.67e-06	4.31e-05	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ALB—breast cancer	6.48e-06	4.19e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—FASN—breast cancer	6.47e-06	4.18e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—BCHE—breast cancer	6.44e-06	4.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC5A5—breast cancer	6.36e-06	4.11e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SIRT1—breast cancer	6.31e-06	4.08e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SMAD4—breast cancer	6.24e-06	4.03e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—VDR—breast cancer	6.22e-06	4.02e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NQO1—breast cancer	6.14e-06	3.97e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC2A1—breast cancer	6.14e-06	3.97e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NCOR1—breast cancer	6.05e-06	3.92e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.01e-06	3.89e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP3A4—breast cancer	5.99e-06	3.87e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CTNNB1—breast cancer	5.97e-06	3.86e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.96e-06	3.85e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—H2AFX—breast cancer	5.9e-06	3.82e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1B1—breast cancer	5.89e-06	3.81e-05	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—RAF1—breast cancer	5.86e-06	3.79e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—breast cancer	5.85e-06	3.79e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HSP90AA1—breast cancer	5.77e-06	3.73e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ERCC2—breast cancer	5.69e-06	3.68e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MAPK3—breast cancer	5.67e-06	3.67e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOA1—breast cancer	5.62e-06	3.63e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—STK11—breast cancer	5.54e-06	3.58e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP19A1—breast cancer	5.54e-06	3.58e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—breast cancer	5.52e-06	3.57e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SRC—breast cancer	5.4e-06	3.49e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—breast cancer	5.26e-06	3.4e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—STAT3—breast cancer	5.2e-06	3.37e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.2e-06	3.36e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MAPK3—breast cancer	5.19e-06	3.36e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—COMT—breast cancer	5.15e-06	3.33e-05	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—breast cancer	5.14e-06	3.32e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTP1—breast cancer	5.12e-06	3.31e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MAPK3—breast cancer	5.09e-06	3.29e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HMOX1—breast cancer	5.05e-06	3.27e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—breast cancer	5.05e-06	3.26e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ITPR1—breast cancer	5.04e-06	3.26e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAPK3—breast cancer	4.97e-06	3.22e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—breast cancer	4.95e-06	3.2e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MAPK3—breast cancer	4.88e-06	3.16e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MAPK3—breast cancer	4.88e-06	3.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCB1—breast cancer	4.85e-06	3.14e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TGFB1—breast cancer	4.82e-06	3.12e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TYMS—breast cancer	4.76e-06	3.08e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR1—breast cancer	4.76e-06	3.08e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—breast cancer	4.75e-06	3.07e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—breast cancer	4.75e-06	3.07e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—breast cancer	4.73e-06	3.06e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTM1—breast cancer	4.71e-06	3.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PLA2G4A—breast cancer	4.71e-06	3.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOR1—breast cancer	4.71e-06	3.04e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH1—breast cancer	4.6e-06	2.97e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GPX1—breast cancer	4.51e-06	2.92e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TNF—breast cancer	4.5e-06	2.91e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—breast cancer	4.47e-06	2.89e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1A1—breast cancer	4.46e-06	2.89e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ERCC2—breast cancer	4.43e-06	2.86e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTHFR—breast cancer	4.16e-06	2.69e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SERPINE1—breast cancer	3.91e-06	2.53e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CAV1—breast cancer	3.84e-06	2.48e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AKT1—breast cancer	3.83e-06	2.48e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HRAS—breast cancer	3.8e-06	2.46e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.67e-06	2.37e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6—breast cancer	3.64e-06	2.35e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AKT1—breast cancer	3.5e-06	2.26e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CG—breast cancer	3.5e-06	2.26e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—breast cancer	3.43e-06	2.22e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT1—breast cancer	3.35e-06	2.17e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—breast cancer	3.29e-06	2.13e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AKT1—breast cancer	3.29e-06	2.13e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CD—breast cancer	3.07e-06	1.99e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALB—breast cancer	3.03e-06	1.96e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NOS3—breast cancer	2.9e-06	1.88e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CB—breast cancer	2.68e-06	1.73e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—breast cancer	2.65e-06	1.72e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MAPK3—breast cancer	2.54e-06	1.64e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—breast cancer	2.47e-06	1.6e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—breast cancer	2.31e-06	1.5e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—breast cancer	1.72e-06	1.11e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—breast cancer	1.63e-06	1.06e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—breast cancer	1.33e-06	8.63e-06	CbGpPWpGaD
